Richard Glasier, a director atCarnival Corp (CCL), recently picked up 10,000 shares. The purchase came to just over $140,000, and increased the director’s stake by 23 percent. This marks the second insider buy of 2020, following a 1.25 million share buy from another director back in early April. Insiders were last sellers in 2019, at prices 70-75 percent higher than where shares currently trade. Shares of the cruise line company have doubled off their March lows. They are still down two-thirds over the past year. The industry largely remains idled, with proposed openings that cont...

Lew Jacobs, a director atCitigroup (C), recently added 10,000 shares. The buy came to just over $440,000, and increased the director’s stake by 77 percent. He now owns over 22,900 shares. The trade marks the first move by insiders since August 2019. Insiders have mostly been sellers in the past two years, but have been inactive for a prolonged time. The last sales were at prices 30-37 percent higher than where shares currently trade. The big banks have had to contend with a financial crisis, and now low-interest rates, which may impact the bank’s profitability for years. Shares of th...

Luke Evnin, a director atOncorus (ONCR), recently added 151,225 shares to his holdings. The value came to over $2.2 million. But he’s hardly alone. A number of funds with substantial holdings have also been adding to their stake here. That includes a 1 million share buy from Deerfield Management, and a 325,000 share buy from Gadicke Ansbert, a major holder. The buys occurred in early October, just a few weeks after the company went public. Oncorus is a clinical-stage biotech firm. Their focus is on viral immunotherapies for cancer patients. The company has a drug in Phase 1 trial ...

Daniel Solomita, President and CEO ofLoop Industries (LOOP), recently bought 10,000 shares. The buy increased his stake by 5 percent, and came to a cost of just over $73,000. He was joined by the company CFO, buying 5,000 shares. Two directors have also been buyers in recent days, each picking up 10,000 shares in the low $8 range. This cluster of insider buying has occurred as shares have been cut nearly in half in the past month. The last insider activity occurred in July 2019, when some C-suite executives made some sales. The share drop occurred as Hindenburg Research released a...

Ares Trading, already a major holder inPrecigen (PGEN), recently added another $25 million investment. At that price, the company was able to pick up 6,758,400 shares. That’s a 32 percent increase to the fund’s stake in the company. The move dwarfs the insider sales in the past month from company insiders. The buy comes as shares of the company have dropped from $15 to under $4 in the past two years. Insiders, including Ares Trading, own over 15 percent of shares. Precigen develops gene and cellular therapies, including disease-modifying therapeutics. As an early-stage biotech compan...

Timothy Springer, a director and major owner atSelecta Biosciences (SELB), recently bought 3,185,394 shares of the company. That trade came to over $5.4 million. The buy increased his total holdings to just over 16.05 million shares. Another director made a 50,000 share buy at the start of October as well. There have been some insider sales in the past year, but they have been dwarfed by insider buys. Insiders own 17 percent of all shares of the immunogenetics company. Shares of the biotech company are up 48 percent in the past year, although shares are trading on the low end of thei...

Richard Anderson, a director atMedtronic PLC (MDT), recently added 4,607 shares. The buy came to a total purchase price of nearly $51,000, and increased the director’s stake by 4.4 percent. This is the second insider buy of 2020, following a buy from the company CEO back in February. Insiders have been a mix of buyers and sellers this year. The share price of the company has held up relatively well in the past year. Although sales and earnings are slightly off in the past year, the medical device manufacturer has managed to continue making a profit. And the company’s balance sheet is...

James Filler, a major owner atCentury Bancorp (CNBKA), recently added 1,002 shares to his stake. A mere 0.12 percent increase, the $69,000 buy increased his holdings to over 848,000 shares. This follows on top of some small share buys from company executives earlier in the month, although Filler has been the major buyer of shares in the past year. The Massachusetts based-bank has 27 offices in the state. Shares have shed 21 percent in the past year, as the decline in interest rates to zero has adversely impacted bank stocks as a whole. Even with that impediment, the bank has managed ...

Dan Hill, a director atNuStar Energy (NS), recently picked up an even 5,000 shares. Paying about $10 per share, the buy came to $50,000. It increased his total holdings to 59,214 shares. This is the first insider buy in six months. Insider buying for 2020 shows a number of insider buys, at prices anywhere from $6 at the March lows to $12. The buys include directors and C-suite executives. Shares have traded between $5 and $30 in the past year at the oil and gas midstream company with a focus on pipeline and storage facilities. That means company insiders have shown good judgment in b...

Harold Hamm, executive chairman atContinental Resources (CLR) recently added 769,235 shares to his holdings. The buy increased his stake to over 296 million shares, and came at a cost of just over $9.7 million. Hamm has been a repeat buyer throughout the year, as have a number of directors and C-level executives earlier in the year. Insiders have bought in a range anywhere from $8 to $16 per share. With shares currently under $13, the price is in the middle of the range that insiders have been buying at in the past year. All told, insiders own nearly 80 percent of the oil and gas exp...